Michael J. Leach
19Patents
6h-index
10Co-inventors
63Inventor score
Filing activity: Jun 6, 1995 → Jul 5, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7935729B2 | Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease | Human Necessities | 17 | Active |
| US5597827A | Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine | Chemistry; Metallurgy | 14 | Expired |
| US5597828A | Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds | Chemistry; Metallurgy | 12 | Expired |
| US5712277A | Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema | Human Necessities | 7 | Expired |
| US5587380A | Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds | Chemistry; Metallurgy | 7 | Expired |
| US5591746A | Treatment of damage from a stroke using 4-amino(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine | Chemistry; Metallurgy | 6 | Expired |
| US8748600B2 | Cyclic triazo sodium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US5684005A | Pharmacologically active CNS compounds | Chemistry; Metallurgy | 4 | Expired |
| US8691818B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 4 | Active |
| US5635507A | Pharmacologically active CNS compounds | Chemistry; Metallurgy | 4 | Expired |
| US8748599B2 | Cyclic triazo sodium channel blockers | Emerging Cross-Sectional Technologies | 3 | Active |
| US5712276A | 2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines | Chemistry; Metallurgy | 3 | Expired |
| US8268823B2 | Medical use of triazine derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US9000155B2 | Cyclic triazo sodium channel blockers | Emerging Cross-Sectional Technologies | 2 | Active |
| US9862691B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 1 | Active |
| US9422253B2 | Cyclic triazo and diazo sodium channel blockers | Emerging Cross-Sectional Technologies | 1 | Active |
| US8114903B2 | Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids | Chemistry; Metallurgy | 0 | Active |
| US7964641B2 | Treatment of neurodegenerative conditions | Chemistry; Metallurgy | 0 | Active |
| US10576086B2 | Triazine derivatives as interferon-gamma inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.